How Much CBD Should I Take? Your Dosage Questions Answered

CBD drops and other CBD products have seen a surge in popularity in the last few years due to their potential health benefits. 

Research suggests that CBD may be effective in treating a range of conditions. But how much CBD should you take and how often? Well, the dosage you take will depend on a number of factors.

Read on to find out how to work out the ideal CBD dosage for you.

how much cbd should i take

What are the uses of CBD?

CBD, or cannabidiol, is one of a number of compounds known as cannabinoids found in the Cannabis sativa plant.

CBD doesn’t have any intoxicating or psychotropic effects, so it won’t get you ‘high’. However, interest in its potential therapeutic properties has been steadily growing over the last few years.

Studies are currently underway around the world to better understand these properties. According to a 2017 World Health Organization report, research so far suggests that CBD could be effective in treating a variety of symptoms and conditions.

There are two medicines containing CBD licensed for use in the UK

  • Epidyolex, which is used to treat rare forms of epilepsy
  • Nabiximols (Sativex), which is used to treat multiple sclerosis-related muscle spasticity

Both are available by prescription only.

What does the research say about CBD dosage?

As there are only two CBD-containing medicines licensed for use in the UK, there is no ‘official’ dosage when CBD is used for other reasons.

It’s important to consult with a medical professional as they may be able to recommend an appropriate dosage that provides the desired therapeutic effect.

Various doses of CBD have been used in clinical studies, ranging from 10 mg – 1,500 mg per day. 

A 2017 literature review concluded that CBD has a favourable safety profile, but highlighted that different individuals and conditions respond to different doses of CBD.

However, it suggested that chronic use and high doses of up to 1,500 mg per day are generally well tolerated by humans.

To determine whether a CBD product is an appropriate treatment for you, you should talk to your doctor before taking anything.

How much CBD should I take?

Whatever your reasons for taking CBD, it’s a good idea to figure out an appropriate dosage to ensure your CBD usage is both safe and effective.

As mentioned previously, there are no official clinical guidelines on how much CBD you should take for treating different conditions. This is due to the fact that CBD products are not allowed to be marketed as medicines.

The dosage you take will depend on a variety of factors, including:

  • Your weight – in clinical trials, researchers often calculate the dosage of CBD per kilogram of body weight. People who weigh less are likely to require a lower dosage of CBD and vice versa
  • The symptoms you’re treating – some conditions like epilepsy may require high doses, while a smaller dosage may be effective to treat less severe conditions
  • Your body chemistry – everybody is built differently, and different people may respond to CBD in different ways, therefore your body chemistry is taken into account when considering how much CBD you should take
  • The type of product – CBD is available in a number of different products, including drops, capsules, tablets, gummies, topical creams, cigarettes, vape products, oral sprays, and beverages, and the amount you should take will depend on which type of product you’re consuming
how much cbd should i take

Consult your GP before taking CBD

Before using any CBD product, you should speak to your doctor about how much to take and any potential risks. 

This is particularly important if you take any other medications. If your doctor advises a particular dosage, you should follow their advice as they’re a trained medical professional.

If your doctor doesn’t recommend a particular dosage, some people suggest that you can work out how much CBD to take by starting with a small amount and increasing it gradually until you find your ideal dose.

For example, you could start by taking 5-10 mg per day of CBD for a week. If you feel like this isn’t effective in treating your symptoms, increase your daily dose by 5 mg for another week, and so on. Repeat this process until you feel like you’re achieving the desired effect.

To aid this process, it’s a good idea to make daily notes of how much CBD you take and whether you notice any changes to your symptoms. When you look back at your notes, you’ll get an idea of which doses are most effective.

Alcohol and medications that slow down brain activity (central nervous system depressants) may increase the sedative effect of CBD. 

If you take medication that causes a sedative effect or you intend to consume alcohol, you may need to lower your CBD dosage or avoid it altogether. 

If this is the case, it’s even more important to seek medical advice from your doctor before taking CBD.

How do I work out the CBD dosage?

Different CBD products contain different amounts of CBD, so working out how much of a particular product to take may require a bit of maths.

Products like CBD oil capsules, gummies or tablets should tell you how much CBD is in a single serving on the packaging or leaflet.

For example, if you look at the packaging for a bottle of CBD gummies, it might tell you that each gummy contains 10 mg of CBD.

However, if you’re taking CBD oil, the label may indicate how much CBD is in a single drop, or it may tell you the bottle’s total CBD content. 

If the label tells you how much CBD is in one drop, then working out how many CBD drops to take should be relatively easy. Use the following formula:

[Target dosage of CBD] ÷ [Amount of CBD in one drop] = [Number of CBD drops to take]

For example, if the label states that there are 2.5 mg of CBD per drop, and you intend to take 20 mg of CBD per day, you would work out your daily dosage as follows:

20 mg ÷ 2.5 mg = 8 drops per day

How many drops in 1 ml?

If the label states the amount of CBD in the entire bottle, you’ll need to do a different calculation to work out how much CBD oil to take. 

Firstly, it’s important to know how many drops there are in 1 ml. A single drop (not a full dropper) equates to about 0.05 ml, meaning there are 20 drops in 1 ml.

From here, you can work out how many drops there are in a particular bottle. You may do so by multiplying the number of millilitres in the bottle by 20. So, if it’s a 10 ml bottle, it will contain:

10 ml x 20 = 200 drops in total

You can then work out the amount of CBD in one drop by using the following calculation:

[Total amount of CBD in the bottle] ÷ [Total number of drops in the bottle] = [Amount of CBD in one drop]

For example, if you have a 10 ml bottle of CBD oil and the label states there are 300 mg of CBD in it, you can work out the CBD content in one drop as follows:

10 ml x 20 = 200 drops

300 mg ÷ 200 drops = 1.5 mg per drop

You can then use the first formula above to work out how many drops you need to take to reach your target dosage. 

Avoid any CBD products that are not clearly labelled. High-quality products should always clearly state their CBD content.

Is it possible to take too much CBD?

Research so far suggests that CBD has relatively low toxicity and is well tolerated by humans, even in high doses.

However, data is limited. In a 2019 study, mice were given the scaled equivalent of the maximum recommended human dose of CBD in Epidyolex (20 mg per kg). The study raised concerns about CBD’s potential for liver damage and interactions with other medications.

As mentioned previously, it’s essential to talk to your doctor before taking CBD if you’re taking any other medications.

Previous studies have suggested that CBD can cause side effects in some individuals, including diarrhoea, decreased appetite, drowsiness and changes in mood.

As always, if you’re concerned about potential side effects, talk to your doctor.

If you’re wondering ‘can you overdose on CBD?’, read our article.

When should I take CBD?

As with CBD dosage, there’s no one-size-fits-all approach. The best time to take CBD oil will vary from person to person.

Some people report a boost in alertness after taking CBD, so taking it first thing in the morning may make sense if this is the case. 

However, CBD makes other people feel sleepy and relaxed, so taking it before bed may work better in these circumstances.

You may choose to take CBD with your evening meal, simply because it’s easy to remember. Ultimately, it’s all down to what works best for you. 

Try taking it at different times of day to see how it affects you.

CBD dosage – how much CBD should I take? A summary

We hope our blog has explained all you need to know about the different dosages of CBD and how much you can take.

If you’d like to learn more about CBD, check out our blog or contact us today!

arrow green back

‘CBD is Not a Narcotic’ says EU Court in CBD Breakthrough

In an exciting development in CBD oil news, the EU’s highest court has ruled that CBD is not a narcotic.

This landmark decision has provided a welcome boost for the European CBD industry, creating a clearer path to full legal compliance for CBD companies.

cbd is not a narcotic says eu court in cbd breakthrough

The latest CBD oil news: CBD is not a narcotic

The ruling by the Court of Justice of the European Union (CJEU) was announced on 19 November 2020. It states that cannabidiol (CBD) is not a narcotic drug because it ‘does not appear to have any psychotropic effect or any harmful effect on human health’.

The ruling came as part of a case known as the ‘KanaVape Case’, which involved the prosecution of French CBD company KanaVape.

KanaVape sold e-cigarettes containing CBD oil derived from whole hemp plants. In French law, only the seeds and fibre of hemp may be used commercially – it’s illegal to use the buds or flowers. CBD oil and UK law are similar in this aspect.

However, the CBD that KanaVape used was produced lawfully in the Czech Republic. Over there, it is legal to use the whole hemp plant to produce CBD oil, and then imported into France.

What does the ruling mean?

The CJEU ruled that the criminal proceedings against KanaVape weren’t consistent with EU law on the free movement of goods. They stated that: ‘A Member State may not prohibit the marketing of cannabidiol (CBD) lawfully produced in another Member State when it is extracted from the Cannabis sativa plant in its entirety and not solely from its fibre and seeds.’

In other words, the EU decision said that France’s ban on marketing hemp-derived CBD products contradicted EU law, as the products in question had been produced legally in another EU member state.


EU laws on the free movement of goods do not apply to narcotic drugs, as the marketing of narcotic drugs is banned in all EU member states. The court, therefore, had to establish whether CBD should be regarded as a narcotic in order to determine whether the French authorities had contradicted EU law.

The court concluded that ‘the provisions on the free movement of goods within the European Union (Articles 34 and 36 TFEU) are applicable. This is because the CBD at issue in the main proceedings cannot be regarded as a ‘narcotic drug’.’

In describing its reasoning in deciding whether CBD could be considered a narcotic, the court cited two UN conventions: 

  • The Convention on Psychotropic Substances: The court noted that CBD is not mentioned in this convention.
  • The Single Convention on Narcotic Drugs: Although this convention makes reference to cannabis extracts, the court observed that interpreting CBD as a drug on this basis would be ‘contrary to the general spirit of that convention and to its objective of protecting ‘the health and welfare of mankind’.’

The court concluded that on this basis, and ‘according to the current state of scientific knowledge’, CBD is not a narcotic drug.

What else did the ruling say?

The ruling stated that a ban by a member state on the marketing of hemp-derived CBD products may be justified ‘by the objective of protecting public health’ but that it ‘must not go beyond what is necessary in order to attain it’.

The court declared that it was for the French national court to assess whether the prohibition in question was justified on those grounds. However, it noted that France hadn’t banned the marketing of synthetic CBD, which has the same properties as CBD and could be used as a substitute for it. The court also stated:

“The national court must assess available scientific data in order to make sure that the real risk to public health alleged does not appear to be based on purely hypothetical considerations. A decision to prohibit the marketing of CBD, which indeed constitutes the most restrictive obstacle to trade in products lawfully manufactured and marketed in other Member States, can be adopted only if that risk appears sufficiently established.”

More about the KanaVape case

The KanaVape case began in 2014. The French authorities deemed KanaVape to be contravening French law by selling products containing CBD extracted from whole hemp plants.

In 2018, the Court of Appeal of Aix-en-Provence overturned the initial ruling. This was on the grounds that it contradicted the EU principle of free movement of goods. The case was then referred to the CJEU. 

The CJEU sought the guidance of Advocate General Evgeni Tanchev. And, in May 2020, Tanchev was of the opinion that CBD should not be considered a narcotic. This view was not legally binding, but the courts do tend to follow the advice of the Advocate General. Therefore, this was seen as a positive development for the CBD sector.

Unfortunately, this optimism was somewhat dampened in July 2020. The European Commission paused all CBD novel food applications while it considered whether CBD should be regarded as a narcotic. Its preliminary stance was that it should, based on a strict reading of the Single Convention on Narcotic Drugs.

However, the November court ruling definitively contradicted this stance and set a precedent for all EU institutions and member states. 

What does the ruling mean for the CBD industry?

The CJEU ruling marked a huge step forward in CBD oil news and is likely to have major ramifications for the CBD industry in Europe. 

The European Commission has since abandoned its stance that CBD should be classed as a narcotic. Novel food applications for CBD products have resumed, which clears the way for CBD companies to achieve full legal compliance for their products.

Adela Williams, Partner at Arnold & Porter, legal counsel to the Association for the Cannabinoid Industry, said:

“This is clearly an important decision for the European CBD industry. The EU’s highest court has decided that EU member states may not prohibit the marketing of CBD products lawfully supplied in other member states unless a real risk to public health has been demonstrated. Furthermore, the European Court has confirmed that CBD should not be classified as a narcotic under the 1961 UN Convention on narcotics, removing an obstacle to the continued assessment of novel food applications relating to CBD products.”

What is CBD?

CBD is one of a group of chemical compounds called cannabinoids found in the Cannabis sativa plant species.

Unlike tetrahydrocannabinol (THC), another well-known cannabinoid, CBD does not cause psychotropic effects – it doesn’t get you ‘high’. CBD is typically extracted from hemp, a variety of Cannabis sativa that contains little or no THC. 

CBD has seen a surge in popularity recently, as interest has developed in its potential therapeutic benefits. The World Health Organisation has said that CBD is ‘generally well tolerated with a good safety profile’. They’ve also outlined that there is no evidence ‘of any public health-related problems associated with the use of pure CBD’.

We’ll be back soon with more CBD oil news, so watch this space for all the latest developments.

arrow green back